Ginkgo Bioworks Holdings, Inc. (DNA) Dividend History

Company News

• Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight

  The microbial fermentation technology market is experiencing significant growth, driven by the increasing incidence of chronic diseases and the growing demand for cutting-edge treatments. North America is expected to dominate the market during the forecast period.

  GlobeNewswire Inc.
• Synthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGR

  The global synthetic biology market is projected to grow from $19.3 billion in 2024 to $61.6 billion by 2029, driven by applications in healthcare, agriculture, and the environment. Factors driving growth include increasing R&D funding, declining DNA sequencing costs, and continuous innovations.

  GlobeNewswire Inc.
• Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research

  Nanorobots, tiny machines ranging from 1 to 100 nanometers in size, are revolutionizing healthcare by enabling targeted drug delivery, cellular repair, and early disease detection. The global nanorobots market in healthcare is rapidly expanding, driven by advancements in nanotechnology and increasing investments in research and development.

  GlobeNewswire Inc.

  Featured Companies: BRKR
• Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023 - Global Forecast to 2030 - Revolutionizing Healthcare with Targeted Drug Delivery and Minimally Invasive Surgeries

  The global nanobots in healthcare market is expected to grow at a CAGR of 8.6% during 2025-2030, driven by advancements in nanotechnology, increasing prevalence of chronic diseases, and growing demand for minimally invasive surgeries. Nanorobots are revolutionizing healthcare by offering new possibilities in diagnostics, targeted drug delivery, and minimally invasive procedures.

  GlobeNewswire Inc.

  Featured Companies: A BRKR TMO
• Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA

  Pomerantz LLP announces a proposed class action settlement of $17.75 million on behalf of purchasers of Ginkgo Bioworks Holdings, Inc. common stock between May 11, 2021 and October 5, 2021. The settlement resolves allegations of false and misleading statements in the company's proxy/registration statement.

  GlobeNewswire Inc.